Changes in cognitive functioning with risperidone and olanzapine treatment: a large-scale, double-blind, randomized study
β Scribed by Philip D. Harvey; Michael F. Green; Susan R. McGurk; Herbert Y. Meltzer
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 167 KB
- Volume
- 169
- Category
- Article
- ISSN
- 0033-3158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Adductor spasticity in children with cerebral palsy **(CP)** impairs motor function and development. In a placeboβcontrolled, doubleβblind, randomized multicentre study, we evaluated the effects of botulinum toxin **A(BTXβA)** in 61 children (37 males, 24 females; mean age 6 years 1 month [SD 3y 1mo
Twenty patients with intractable rheumatoid arthritis were treated with 750-rad or 2,000-rad lymphoid irradiation in a randomized double-blind comparative study. Over a 12-month followup period, there was a significant improvement in 4 of 7 and 6 of 7 standard parameters of disease activity followin
## Abstract ## Objective To assess combined antidepressant and cognitive enhancer treatment in elderly patients presenting with depression plus cognitive impairment. ## Methods Twentyβthree elderly (>50 years old) depressed, cognitively impaired (DEPβCI) patients participated in a pilot study. W
## Abstract ## Objective It has been reported that selegiline, a Selective Monoamine Oxidase Inhibitor B (MAOIβB), at low doses would be helpful for treating negative symptoms in schizophrenia. Nevertheless, the results are contradictory so far. This study was designed to investigate the effect of